The Boston Globe
Renowned MGB neuroscientist's efforts to combat Alzheimer's to receive tens of millions of dollars
xCruzo Brief
Rudolph Tanzi, a Mass General Brigham (MGB) neuroscientist who helped discover key Alzheimer’s genes, is set to receive up to $41 million in federal health grants plus $25 million from philanthropists for a four-year study. The project will test five to 10 drug combinations Tanzi developed as potential treatments for the most common form of dementia. Separately, Acta Pharmaceuticals, a Boston biotech cofounded by Tanzi, said last week it raised $24 million in seed financing to start a clinical trial of an experimental medicine from a drug class he helped discover. Tanzi, 68, frames prevention as akin to statins for cholesterol.
xCruzo quick-read summary • Source: The Boston Globe • Read the full article for complete information.
xCruzo
Things banned in the U.S., from candy to cheese
Machine Learning Shows Promise but Limited Clinical Validation in
LDA pathology features lead thyroid cancer recurrence model
Pueblo students work with local foods for Farm to School Month
La dieta de Luis Enrique (56 años): 'He llegado a cenar seis huevos. Es uno de los alimentos con más nutrientes, nunca falta en mi dieta'
Estudiante de la Universidad de Arizona afirma haber sido agredida sexualmente por dos hombres en una fraternidad
Vacuna contra la gripe gratis en NYC: dónde conseguirla sin seguro médico
Camila Ramón